Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Interleukin enhancer-binding factor 3 (ILF3) (AA 785-894) anticorps

ILF3 Reactivité: Humain WB, IHC, ELISA Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN7156720
  • Antigène Voir toutes Interleukin enhancer-binding factor 3 (ILF3) Anticorps
    Interleukin enhancer-binding factor 3 (ILF3)
    Épitope
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 785-894
    Reactivité
    • 57
    • 40
    • 37
    • 14
    • 11
    • 11
    • 10
    • 5
    • 5
    • 5
    • 2
    • 2
    • 1
    • 1
    Humain
    Hôte
    • 52
    • 3
    • 1
    Lapin
    Clonalité
    • 45
    • 12
    Polyclonal
    Conjugué
    • 43
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    Inconjugué
    Application
    • 37
    • 16
    • 10
    • 10
    • 10
    • 9
    • 5
    • 3
    • 2
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC), ELISA
     Réactivité croisée
    Humain
    Purification
    Antigen Affinity Purified
    Immunogène
    Recombinant Human Interleukin enhancer-binding factor 3 protein (785-894AA)
    Isotype
    IgG
    Top Product
    Discover our top product ILF3 Anticorps primaire
  • Indications d'application
    Recommended dilution: WB:1:200-1:1000, IHC:1:20-1:200,
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C,-80 °C
    Stockage commentaire
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Antigène
    Interleukin enhancer-binding factor 3 (ILF3)
    Autre désignation
    ILF3 (ILF3 Produits)
    Synonymes
    anticorps CBTF, anticorps DRBF, anticorps DRBP76, anticorps MMP4, anticorps MPHOSPH4, anticorps MPP4, anticorps NF-AT-90, anticorps NF110, anticorps NF110b, anticorps NF90, anticorps NF90a, anticorps NF90b, anticorps NFAR, anticorps NFAR-1, anticorps NFAR2, anticorps TCP110, anticorps TCP80, anticorps MBII-26, anticorps ilf3, anticorps wu:fb37d07, anticorps wu:fb94b02, anticorps zgc:77030, anticorps 4F.1, anticorps cbtf122, anticorps ilf3-A, anticorps ubp3, anticorps ubp4, anticorps xilf3, anticorps interleukin enhancer binding factor 3, anticorps interleukin enhancer binding factor 3b, anticorps interleukin enhancer binding factor 3 S homeolog, anticorps ILF3, anticorps Ilf3, anticorps ilf3b, anticorps ilf3.S
    Sujet

    Background: May facilitate double-stranded RNA-regulated gene expression at the level of post-transcription. Can act as a translation inhibitory protein which binds to coding sequences of acid beta-glucosidase (GCase) and other mRNAs and functions at the initiation phase of GCase mRNA translation, probably by inhibiting its binding to polysomes. Can regulate protein arginine N-methyltransferase 1 activity. May regulate transcription of the IL2 gene during T-cell activation. Can promote the formation of stable DNA-dependent protein kinase holoenzyme complexes on DNA. The phosphorylated form at Thr-188 and Thr-315, in concert with EIF2AK2/PKR can inhibit vesicular stomatitis virus (VSV) replication (By similarity).

    Aliases: CBTF antibody, Double stranded RNA binding protein 76 antibody, Double-stranded RNA-binding protein 76 antibody, DRBF antibody, DRBP76 antibody, ILF3 antibody, ILF3_HUMAN antibody, Interleukin enhancer binding factor 3 antibody, Interleukin enhancer-binding factor 3 antibody, M phase phosphoprotein 4 antibody, M-phase phosphoprotein 4 antibody, MPHOSPH4 antibody, MPP4 antibody, NF AT 90 antibody, NF-AT-90 antibody, NF110 antibody, NF90 antibody, NFAR antibody, Nuclear factor associated with dsRNA antibody, Nuclear factor of activated T cells 90 kDa antibody, Nuclear factor of activated T-cells 90 kDa antibody, TCP80 antibody, Translational control protein 80 antibody

    UniProt
    Q12906
    Pathways
    M Phase
Vous êtes ici: